89bio Inc (ETNB)
7.98
+0.04
(+0.50%)
USD |
NASDAQ |
Dec 26, 13:11
89bio Cash from Investing (Quarterly): -8.639M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | -202.39M |
| Eli Lilly and Co | -4.005B |
| Viking Therapeutics Inc | 25.90M |
| Akero Therapeutics Inc | 73.07M |
| NovaBay Pharmaceuticals Inc | -0.002M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -145.36M |
| Cash from Financing (Quarterly) | 33.19M |
| Free Cash Flow | -280.54M |
| Free Cash Flow Per Share (Quarterly) | -1.358 |
| Free Cash Flow Yield | -36.66% |